|
JAK Inhibition in Down Syndrome |
4R33AR077495-03 |
|
NIAMS |
2022 |
|
Addressing knowledge gaps by multi-level research design to optimize clinical trial development in order to reduce fracture burden for adults with neurodevelopmental disabilities |
5R01AR076994-02 |
|
NIAMS |
2022 |
|
Multi-site Randomized Clinical Trial of FIT Teens for Juvenile Fibromyalgia |
5 R01 AR070474-05 |
KASHIKAR-ZUCK, SUSMITA |
NIAMS |
2021 |
|
Data-Driven Framework for Classification and Surgical Planning of Spinal Deformity. |
5 R21 AR075971-02 |
PASHA, SABA |
NIAMS |
2021 |
|
DEVELOPMENT AND APPLICATION OF MUSCLE DIFFUSION TENSOR MRI |
1R01AR073831-01A1 |
DAMON, BRUCE M. |
NIAMS |
2019 |
|
ULTRASOUND-COUPLED ELECTRICAL IMPEDANCE TOMOGRAPHY FOR ASSESSMENT OF NEUROMUSCULAR DISORDERS |
1R41AR076912-01 |
HALTER, RYAN JOSEPH |
NIAMS |
2019 |
|
JAK INHIBITION IN DOWN SYNDROME |
1R61AR077495-01 |
ESPINOSA, JOAQUIN M. |
NIAMS |
2019 |
|
MAGNETIC RESONANCE IMAGING AND BIOMARKERS FOR MUSCULAR DYSTROPY |
5R01AR056973-10 |
VANDENBORNE, KRISTA H |
NIAMS |
2019 |
|
DEFINITION OF PHARMACODYNAMIC BIOMARKERS FOR JUVENILE DERMATOMYOSITIS FOR CLINICAL TRIALS |
1R43AR073547-01 |
HOFFMAN, ERIC P. |
NIAMS |
2018 |
|
INNOVATIVE ELECTRODE DESIGNS FOR NEXT GENERATION ELECTRICAL IMPEDANCE MYOGRAPHY |
1R43AR074805-01 |
LUPTON, ELMER C |
NIAMS |
2018 |